Download PDF
Thromb Haemost 2007; 97(06): 899-906
DOI: 10.1160/TH06-12-0697
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: Possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors

Likui Yang
1   Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA
,
Alireza R. Rezaie
1   Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA
› Author AffiliationsFinancial support: The research discussed here in was supported by grants awarded by the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL 62565 and HL 68571 to ARR).
Further Information

Publication History

Received 06 December 2006

Accepted after resubmission 05 March 2007

Publication Date:
27 November 2017 (online)

    Permissions and Reprints

Summary

The Ca2+-dependence of protein C activation by thrombin in complex with thrombomodulin (TM) containing chondroitin sulfate (CS) exhibits saturation at ~0.5–1 mM Ca2+, but withTM lacking CS, it has a distinct optimum at ~0.1 mM Ca2+. Since the substrate protein C has multiple Ca2+-binding sites, and the cofactor TM also interacts with Ca2+, the basis for differences in Ca2+ effect on protein C activation by thrombin in complex with TM containing or lacking CS is not known. In this study, by using full-length and Gla-domainless mutants of protein C whose activation by thrombin is independent of either Ca2+ or both Ca2+ and TM, we demonstrate that i) the Ca2+ occupancy of a high-affinity binding site in TM is essential for the high-affinity interaction of the cofactor with thrombin, ii) the Ca2+ occupancy of a binding site (KD ~50 μM) in the catalytic domain of protein C is required for the substrate recognition by the thrombin-TM complex, however, at this concentration of Ca2+ the Gla domain of protein C is not folded properly and thus interacts with exosite-2 of thrombin in complex with TM that lacks CS but not withTM that contains CS, and finally iii) platelet factor 4 can nonspecifically interact with the Gla domain of protein C and other coagulation factors to influence their activation only at subphysiological concentrations of Ca2+.

Keywords

Thrombomodulin - chondroitin sulfate - protein C - thrombin - calcium - platelet factor 4
 

  • References

  • 1 Stenflo J. Structure-function relationships of epidermal growth factor modules in vitamin K dependent clotting factors. Blood 1991; 78: 1637-1651.
    PubMedGoogle Scholar
  • 2 Esmon CT, Esmon NL. Protein C activation. Sem Thromb Hemost 1984; 10: 122-130.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J 1992; 6: 2561-2567.
    CrossrefPubMedGoogle Scholar
  • 4 Dahlbäck B. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost 1995; 74: 139-148.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Mather T, Oganessyan V, Hof P. et al. The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO J 1996; 15: 6822-6831.
    PubMedGoogle Scholar
  • 6 Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 1993; 70: 1-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Xu H, Bush LA, Pineda AO. et al. Thrombomodulin changes the molecular surface of interaction and the rate of complex formation between thrombin and protein C. J Biol Chem 2005; 280: 7956-7961.
    CrossrefPubMedGoogle Scholar
  • 8 Bode W, Mayr I, Baumann U. et al. The refined 1.9 Å crystal structure of human α -thrombin: interaction with D-Phe-Pro-Arg chlorometheylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989; 8: 3467-3475.
    PubMedGoogle Scholar
  • 9 Rezaie AR, Esmon NL, Esmon CT. The high affinity calcium-binding site involved in protein C activation is outside the first epidermal growth factor homology domain. J Biol Chem 1992; 267: 11701-11704.
    PubMedGoogle Scholar
  • 10 Rezaie AR, Mather T, Sussman F. et al. Mutation of Glu 80 to Lys results in a protein C mutant that no longer requires Ca2+ for rapid activation by the thrombinthrombomodulin complex. J Biol Chem 1994; 269: 3151-3154.
    PubMedGoogle Scholar
  • 11 Bode W, Schwager P. The refined crystal structure of bovine beta-trypsin at 1.8 Å resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. J Mol Biol 1975; 98: 693-717.
    CrossrefPubMedGoogle Scholar
  • 12 Öhlin A, Landes G, Bourdon P. et al. β -Hydroxyaspartic acid in the first epidermal growth factor-like domain of protein C: Its role in Ca 2+ binding and biological activity. J Biol Chem 1988; 263: 19240-19248.
    PubMedGoogle Scholar
  • 13 Rezaie AR, Esmon CT. The function of calcium in protein C activation by thrombin and the thrombinthrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem 1992; 267: 26104-26109.
    PubMedGoogle Scholar
  • 14 Fukudome K, Esmon CT. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994; 269: 26486-26491.
    PubMedGoogle Scholar
  • 15 Oganesyan V, Oganesyan N, Terzyan S. et al. The crystal structure of the endothelial protein C receptor and a bound phospholipid. J Biol Chem 2002; 277: 24851-24854.
    CrossrefPubMedGoogle Scholar
  • 16 Fuentes-Prior P, Iwanaga Y, Huber R. et al. Structural basis for the anticoagulant activity of the thrombin- thrombomodulin complex. Nature 2000; 404: 518-525.
    CrossrefPubMedGoogle Scholar
  • 17 Grutter MG, Priestle JP, Rahuel J. et al. Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J 1990; 9: 2361-2365.
    PubMedGoogle Scholar
  • 18 Ye J, Esmon NL, Esmon CT. et al. The active site of thrombin is altered upon binding to thrombomodulin: Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J Biol Chem 1991; 266: 23016-23021.
    PubMedGoogle Scholar
  • 19 Zushi M, Gomi K, Yamamoto S. et al. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 1989; 264: 10351-10353.
    PubMedGoogle Scholar
  • 20 Stearns DJ, Kurosawa S, Esmon CT. Micro-thrombomodulin: Residues 310–486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation. J Biol Chem 1989; 264: 3352-3356.
    PubMedGoogle Scholar
  • 21 Meininger DP, Hunter MJ, Komives EA. Synthesis, activity, and preliminary structure of the fourth EGFlike domain of thrombomodulin. Protein Sci 1995; 4: 1683-1695.
    CrossrefPubMedGoogle Scholar
  • 22 Yang L, Rezaie AR. The fourth epidermal growth factor-like domain of thrombomodulin interacts with the basic exosite of protein C. J Biol Chem 2003; 278: 10484-10490.
    CrossrefPubMedGoogle Scholar
  • 23 Knobe K, Berntsdotter A, Shen L. et al. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling. Proteins 1999; 35: 218-234.
    CrossrefPubMedGoogle Scholar
  • 24 Gale AJ, Griffin JH. Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site of factor Va. Proteins 2004; 54: 433-441.
    CrossrefPubMedGoogle Scholar
  • 25 Liu L, Rezaie AR, Carson CW. et al. Occupancy of anion binding exosite 2 on thrombin determines Ca2+ dependence of protein C activation. J Biol Chem 1994; 269: 11807-11812.
    PubMedGoogle Scholar
  • 26 Bourin MC, Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem J 1993; 289: 313-330.
    CrossrefPubMedGoogle Scholar
  • 27 Church FC, Pratt CW, Noyes CM. et al. Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gammaT - thrombin. J Biol Chem 1989; 264: 18419-18425.
    PubMedGoogle Scholar
  • 28 He X, Ye J, Esmon CT. et al. Influence of arginine 93, 97, and 101 of thrombin to its functional specificity. Biochemistry 1997; 36: 8969-8976.
    CrossrefPubMedGoogle Scholar
  • 29 Parkinson JF, Grinnell BW, Moore RE. et al. Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem 1990; 265: 12602-12610.
    PubMedGoogle Scholar
  • 30 Slungaard A, Key NS. Platelet factor 4 stimulates thrombomodulin protein C-activating cofactor activity. A structure-function analysis. J Biol Chem 1994; 269: 25549-25556.
    PubMedGoogle Scholar
  • 31 Amphlett GW, Kisiel W, Castellino FJ. Interaction of calcium with bovine plasma protein C. Biochemistry 1981; 20: 2156-2161.
    CrossrefPubMedGoogle Scholar
  • 32 Light DR, Glaser CB, Betts M. et al. The interaction of thrombomodulin with Ca2+. Eur J Biochem 1999; 262: 522-533.
    CrossrefPubMedGoogle Scholar
  • 33 Yang L, Manithody C, Rezaie AR. Activation of protein C by the thrombin-thrombomodulin complex: Cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc Natl Acad Sci USA 2006; 103: 879-884.
    CrossrefPubMedGoogle Scholar
  • 34 Smirnov MD, Safa O, Regan LM. et al. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem 1998; 273: 9031-9040.
    CrossrefPubMedGoogle Scholar
  • 35 Rezaie AR. Reactivities of the S2 and S3 subsite residues of thrombin with the native and heparin-induced conformers of antithrombin. Protein Sci 1998; 7: 349-357.
    CrossrefPubMedGoogle Scholar
  • 36 Rezaie AR, Yang L. Deletion of the 60-loop provides new insights into the substrate and inhibitor specificity of thrombin. Thromb Haemost 2005; 93: 1047-1054.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 1994; 269: 816-819.
    PubMedGoogle Scholar
  • 38 Sheehan JP, Sadler JE. Molecular mapping of the heparin-binding exosite of thrombin. Proc Natl Acad Sci USA 1994; 91: 5518-5522.
    CrossrefPubMedGoogle Scholar
  • 39 Gan Z-R, Li Y, Chen Z. et al. Identification of basic amino acid residues in thrombin essential for heparincatalyzed inactivation by antithrombin III. J Biol Chem 1994; 269: 1301-1305.
    PubMedGoogle Scholar
  • 40 Tsiang M, Jain AK, Gibbs CS. Functional requirement for inhibition of thrombin by antithrombin III in the presence and absence of heparin. J Biol Chem 1997; 272: 12024-12029.
    CrossrefPubMedGoogle Scholar
  • 41 Slungaard A. Platelet factor 4 modulation of the thrombomodulin-protein C system. Crit Care Med 2004; 32: S331-335.
    CrossrefPubMedGoogle Scholar
  • 42 Eslin DE, Zhang C, Samuels KJ. et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood 2004; 104: 3173-3180.
    CrossrefPubMedGoogle Scholar